2018
DOI: 10.1136/bcr-2017-223159
|View full text |Cite
|
Sign up to set email alerts
|

Low-dose warfarin maternal anticoagulation and fetal warfarin syndrome

Abstract: Fetuses exposed to warfarin during pregnancy are at an increased risk of developing an embryopathy known as fetal warfarin syndrome or warfarin embryopathy. The most consistent anomalies are nasal hypoplasia and stippling of vertebrae or bony epiphyses. Management of pregnant patients on anticoagulation is challenging. Current guidelines suggest the use of warfarin if the therapeutic dose is ≤5 mg/day. We report the case of a newborn with signs of warfarin embryopathy born from a mother anticoagulated with war… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 19 publications
0
7
0
Order By: Relevance
“…The child in the present case was exposed to warfarin during the first trimester and was diagnosed with warfarin embryopathy in the form of hypoplastic nasal bone/stippling of cartilage in the femur and calceneum. These congenital anomalies have been common findings in children born to mothers with warfarin intake during the first trimester 15–17. The appearance of the nose is often flattened and upturned and has been attributed to the nasal hypoplasia and depression of the bridge of the nose.…”
Section: Discussionmentioning
confidence: 99%
“…The child in the present case was exposed to warfarin during the first trimester and was diagnosed with warfarin embryopathy in the form of hypoplastic nasal bone/stippling of cartilage in the femur and calceneum. These congenital anomalies have been common findings in children born to mothers with warfarin intake during the first trimester 15–17. The appearance of the nose is often flattened and upturned and has been attributed to the nasal hypoplasia and depression of the bridge of the nose.…”
Section: Discussionmentioning
confidence: 99%
“…Although warfarin is the safest anticoagulant for the mother when used during pregnancy, it does have the potential to cause fetal disease [19]. However, the true incidence of fetal embryopathy when warfarin is administered remains controversial and appears to depend on the dose and duration of pregnancy exposure [20].…”
Section: Discussionmentioning
confidence: 99%
“…5,9,10 The absolute contraindications of warfarin use are pregnancy for fear of Fetal warfarin syndrome causing fetal malformations and an increased risk of spontaneous abortion and stillbirths. 11 The INR need to be repeated within 1 to 7 days in all patients on anticoagulants to ensure it within the therapeutic range of 2.0 to 3.0 and at least 2 to 4 weekly during the maintenance phase. INR should also be checked at starting, discontinuing and changing doses of drugs that are known to interact with warfarin.…”
Section: Discussionmentioning
confidence: 99%